Ceapro Inc V.CZO

Last day of tax loss selling in Canada and the US...

[prophetoffactz]

Will there be a webinar detailing the priorities and plans of the new company in the New Year and the path to commercial revenue, etc.

AEZS's diagnostic test trial is expected to be enrolled this month. The 5X PGX scale-up facility is expected to be built this month with commissioning by the end of Q1 as Natex works on the 10X scale-up(commercial scale). Powder beta glucan was expected to be launched "very, very soon" with Symrise as of Gilles October presentation. A North American deal on the diagnostic as it is approved for the key childhood market and a PGX deal as PGX reaches commercial-scale for the first time could be game-changing. And it could all happen on NASDAQ as the Phase I safety/tolerability profile for the avenanthramide pill is estblished, the wound healing program advances to partnership, and PGX-fibrosis moves into the clinic. AEZS's AIM Biologicals could also move towards the clinic.  
 

[Tencents]

I suppose we will have to wai and see the announcement talks about long term growth and opportunities etc but no reasons given to support why aezs financial statements 2023 state they expect significant losses for the foreseeable future  czo say the base business will come back eventually  A webinar showing what when and how much would be useful 

[prophetoffactz]

"A webinar showing what when and how much would be useful..."  Carolyn Egbert, Chair of Aeterna. “Ceapro has well-established and growing commercial operations, with potential value-creating pipeline opportunities in large and growing cosmetic and consumer health markets. We believe that the new company will have the capital resources to support this ongoing growth, in addition to

[Tencents]

Yes exactly the point Carolyn in a wrbincar could bring some granularity to what she is saying - growing commercial operations - negative 2023 by 40 % - negative or positive 2024/2025/2026 - potentiel value creating opportunites - which opportunities/ how much value / when  when if ever will the 49 m plant be built and where will the funds come from  how will aezs significant losses for

[Ciao]

A webinar will bring false hope. You can look back at all the NR / webcasts from AEZS over the past decade or more. At the end of the day, results matter and over the past decades plus, one thing is clear, shareholder value has been devasted. There's no synergy in this merger except for Gilles taking over as the CEO again. It's a new grift where PGX will be touted to retail investors to

[tigerpro]

Agreed.  Both companies management teams are liars without integrity.  Gilles built the corporate culture for both companies as a CEO and director.     If shareholders still believe Gilles and let him continues, both companies' stock price will be 0.      

[lscfa]

No webinar required. Both co's will lay out their cases in voting circulars